Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Cholinomimetic agents and neurocognitive impairment following head injury: a systematic review.

Poole NA, Agrawal N.

Brain Inj. 2008 Jul;22(7-8):519-34. doi: 10.1080/02699050802132495. Review.

PMID:
18568705
2.
3.

Brain injury, cognitive impairment, and donepezil.

Whitlock JA Jr.

J Head Trauma Rehabil. 1999 Aug;14(4):424-7. No abstract available.

PMID:
10407214
7.

Effective treatment of traumatic brain injury: learning from experience.

Ruff RL, Riechers RG.

JAMA. 2012 Nov 21;308(19):2032-3. doi: 10.1001/jama.2012.14008. No abstract available.

PMID:
23168827
8.

Donepezil for cognitive deficits following traumatic brain injury: a case report.

Bourgeois JA, Bahadur N, Minjares S.

J Neuropsychiatry Clin Neurosci. 2002 Fall;14(4):463-4. No abstract available.

PMID:
12426418
9.

[Donepezil therapy in patients with vascular and post-traumatic cognitive impairment: some clinical observations].

Olazarán-Rodríguez J, Cruz-Orduña I, Jiménez-Martín I.

Rev Neurol. 2004 May 16-31;38(10):938-43. Spanish.

10.

A new treatment for hypoxic brain injury?

Flood P.

Anesth Analg. 2007 Sep;105(3):559-60. No abstract available.

PMID:
17717206
11.

Efficacy of nicergoline in dementia and other age associated forms of cognitive impairment.

Fioravanti M, Flicker L.

Cochrane Database Syst Rev. 2001;(4):CD003159. Review.

PMID:
11687175
12.

The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review.

Ballesteros J, Güemes I, Ibarra N, Quemada JI.

J Head Trauma Rehabil. 2008 May-Jun;23(3):171-80. doi: 10.1097/01.HTR.0000319935.99837.96. Review. No abstract available.

PMID:
18520431
13.

Physostigmine reverses cognitive dysfunction caused by moderate hypoxia in adult mice.

Bekker A, Haile M, Gingrich K, Wenning L, Gorny A, Quartermain D, Blanck T.

Anesth Analg. 2007 Sep;105(3):739-43.

PMID:
17717233
14.

Citicoline, use in cognitive decline: vascular and degenerative.

García-Cobos R, Frank-García A, Gutiérrez-Fernández M, Díez-Tejedor E.

J Neurol Sci. 2010 Dec 15;299(1-2):188-92. doi: 10.1016/j.jns.2010.08.027. Epub 2010 Sep 27. Review.

PMID:
20875651
15.

Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment?

Stiles MM, Martin S, Persons RK.

J Fam Pract. 2006 May;55(5):435-6. Review. No abstract available.

PMID:
16670040
16.

Successful use of donepezil in treatment of cognitive impairment caused by maintenance electroconvulsive therapy: a case report.

Rao NP, Palaniyappan P, Chandur J, Venkatasubramanian G, Gangadhar BN.

J ECT. 2009 Sep;25(3):216-8. doi: 10.1097/YCT.0b013e3181926ada.

PMID:
19190508
17.

Investigational treatment for vascular cognitive impairment.

Birks J, Flicker L.

Expert Opin Investig Drugs. 2007 May;16(5):647-58. Review.

PMID:
17461738
18.
19.

Utilization of the Dementia Rating Scale-2 and cognitive enhancers in the diagnosis and treatment of cognitive disorders and dementia.

Caston JC, Diehl LA, Hedgepath AW.

J S C Med Assoc. 2004 Feb;100(2):32-8. No abstract available.

PMID:
15040232
20.

Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.

Cohen RA, Browndyke JN, Moser DJ, Paul RH, Gordon N, Sweet L.

Cerebrovasc Dis. 2003;16(3):199-204.

PMID:
12865605

Supplemental Content

Support Center